Cargando…
Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
Thymic epithelial tumors (TETs) are a group of rare thoracic malignancies, including thymic carcinomas (TC) and thymomas (Tm). Autoimmune paraneoplastic diseases are often observed in TETs, especially Tms. To date, chemotherapy is still the standard treatment for advanced disease. Unfortunately, few...
Autores principales: | Tateo, Valentina, Manuzzi, Lisa, De Giglio, Andrea, Parisi, Claudia, Lamberti, Giuseppe, Campana, Davide, Pantaleo, Maria Abbondanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730788/ https://www.ncbi.nlm.nih.gov/pubmed/33260538 http://dx.doi.org/10.3390/ijms21239056 |
Ejemplares similares
-
An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances
por: Tateo, Valentina, et al.
Publicado: (2021) -
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020) -
Characteristics of Immunobiology in the Tumor Microenvironment- Development of Immunotherapies
por: Song, Jian, et al.
Publicado: (2019) -
Proteoglycans and Immunobiology of Cancer—Therapeutic Implications
por: Tzanakakis, George, et al.
Publicado: (2019) -
Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
por: Cardinale, Antonella, et al.
Publicado: (2021)